story of the week
First-Line Paclitaxel ± Atezolizumab for Unresectable Locally Advanced/Metastatic Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology